Go Pro

Warby Parker (WRBY) Competitors

Warby Parker logo
$27.47 -1.58 (-5.44%)
Closing price 07/13/2026 03:59 PM Eastern
Extended Trading
$27.40 -0.07 (-0.25%)
As of 05:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

WRBY vs. PEN, GKOS, LQDA, BLCO, and STVN

Should you buy Warby Parker stock or one of its competitors? MarketBeat compares Warby Parker with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Warby Parker include Penumbra (PEN), Glaukos (GKOS), Liquidia (LQDA), Bausch + Lomb (BLCO), and Stevanato Group (STVN). These companies are all part of the "medical equipment" industry.

How does Warby Parker compare to Penumbra?

Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

Penumbra has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Penumbra's return on equity of 10.87% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Penumbra 11.76%10.87%8.45%

93.2% of Warby Parker shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 16.8% of Warby Parker shares are held by insiders. Comparatively, 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Penumbra had 1 more articles in the media than Warby Parker. MarketBeat recorded 5 mentions for Penumbra and 4 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.41 beat Penumbra's score of 0.00 indicating that Warby Parker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Penumbra
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Warby Parker currently has a consensus target price of $29.82, indicating a potential upside of 8.55%. Penumbra has a consensus target price of $360.33, indicating a potential upside of 13.09%. Given Penumbra's higher probable upside, analysts plainly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67
Penumbra
1 Sell rating(s)
14 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.11

Penumbra has higher revenue and earnings than Warby Parker. Penumbra is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M3.37$1.64M$0.021,373.45
Penumbra$1.45B8.62$177.69M$4.3473.41

Warby Parker has a beta of 1.91, suggesting that its share price is 91% more volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

Summary

Penumbra beats Warby Parker on 9 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Glaukos?

Glaukos (NYSE:GKOS) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

99.0% of Glaukos shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 5.9% of Glaukos shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Warby Parker has a net margin of 0.15% compared to Glaukos' net margin of -34.34%. Warby Parker's return on equity of 2.30% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-34.34% -6.92% -5.25%
Warby Parker 0.15%2.30%1.18%

Glaukos has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, indicating that its stock price is 91% more volatile than the broader market.

In the previous week, Glaukos had 7 more articles in the media than Warby Parker. MarketBeat recorded 11 mentions for Glaukos and 4 mentions for Warby Parker. Glaukos' average media sentiment score of 0.65 beat Warby Parker's score of 0.41 indicating that Glaukos is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Warby Parker has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$551.35M16.27-$187.69M-$3.28N/A
Warby Parker$871.91M3.37$1.64M$0.021,373.45

Glaukos presently has a consensus price target of $151.77, suggesting a potential downside of 0.65%. Warby Parker has a consensus price target of $29.82, suggesting a potential upside of 8.55%. Given Warby Parker's higher possible upside, analysts plainly believe Warby Parker is more favorable than Glaukos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Warby Parker beats Glaukos on 10 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Liquidia?

Liquidia (NASDAQ:LQDA) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

64.5% of Liquidia shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 25.6% of Liquidia shares are held by insiders. Comparatively, 16.8% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Liquidia has a net margin of 7.74% compared to Warby Parker's net margin of 0.15%. Liquidia's return on equity of 46.82% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Liquidia7.74% 46.82% 7.06%
Warby Parker 0.15%2.30%1.18%

In the previous week, Liquidia had 7 more articles in the media than Warby Parker. MarketBeat recorded 11 mentions for Liquidia and 4 mentions for Warby Parker. Liquidia's average media sentiment score of 0.54 beat Warby Parker's score of 0.41 indicating that Liquidia is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Liquidia
5 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Liquidia has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, indicating that its stock price is 91% more volatile than the broader market.

Warby Parker has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquidia$158.32M40.00-$68.92M$0.14508.64
Warby Parker$871.91M3.37$1.64M$0.021,373.45

Liquidia presently has a consensus price target of $68.88, suggesting a potential downside of 3.28%. Warby Parker has a consensus price target of $29.82, suggesting a potential upside of 8.55%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Liquidia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liquidia
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
3 Strong Buy rating(s)
2.82
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Liquidia beats Warby Parker on 10 of the 17 factors compared between the two stocks.

How does Warby Parker compare to Bausch + Lomb?

Warby Parker (NYSE:WRBY) and Bausch + Lomb (NYSE:BLCO) are both mid-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Warby Parker has a net margin of 0.15% compared to Bausch + Lomb's net margin of -4.21%. Bausch + Lomb's return on equity of 3.60% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Bausch + Lomb -4.21%3.60%1.69%

In the previous week, Bausch + Lomb had 3 more articles in the media than Warby Parker. MarketBeat recorded 7 mentions for Bausch + Lomb and 4 mentions for Warby Parker. Bausch + Lomb's average media sentiment score of 0.56 beat Warby Parker's score of 0.41 indicating that Bausch + Lomb is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bausch + Lomb
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M3.37$1.64M$0.021,373.45
Bausch + Lomb$5.10B1.14-$360M-$0.62N/A

93.2% of Warby Parker shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 16.8% of Warby Parker shares are held by company insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Warby Parker has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Warby Parker presently has a consensus target price of $29.82, indicating a potential upside of 8.55%. Bausch + Lomb has a consensus target price of $18.00, indicating a potential upside of 10.77%. Given Bausch + Lomb's higher possible upside, analysts clearly believe Bausch + Lomb is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67
Bausch + Lomb
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.21

Summary

Warby Parker beats Bausch + Lomb on 10 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Stevanato Group has higher revenue and earnings than Warby Parker. Stevanato Group is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.34B4.46€158.21M€0.5933.52
Warby Parker$871.91M3.37$1.64M$0.021,373.45

Stevanato Group has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market.

Warby Parker has a consensus target price of $29.82, indicating a potential upside of 8.55%. Given Warby Parker's higher possible upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
2.83
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67

Stevanato Group has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Stevanato Group's return on equity of 10.27% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.76% 10.27% 6.08%
Warby Parker 0.15%2.30%1.18%

In the previous week, Warby Parker had 3 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Warby Parker and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Warby Parker's score of 0.41 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

93.2% of Warby Parker shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Stevanato Group beats Warby Parker on 10 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$3.11B$30.64B$16.39B$23.46B
Dividend YieldN/A3.22%3.33%4.02%
P/E Ratio1,374.1475.9726.3931.08
Price / Sales3.371.6144.2019.77
Price / Cash46.1713.6313.3718.64
Price / Book7.8911.155.984.77
Net Income$1.64M$1.30B$668.93M$1.06B
7 Day Performance-2.15%-3.30%-1.50%-0.23%
1 Month Performance4.35%-1.42%-2.46%-0.11%
1 Year Performance19.35%-15.20%-13.17%16.46%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.8697 of 5 stars
$27.47
-5.4%
$29.82
+8.6%
+23.7%$3.11B$871.91M1,374.144,036
PEN
Penumbra
1.6224 of 5 stars
$318.11
-0.1%
$360.33
+13.3%
+34.2%$12.53B$1.40B73.304,700
GKOS
Glaukos
1.6838 of 5 stars
$148.66
+0.2%
$150.62
+1.3%
+47.3%$8.71B$507.44MN/A1,094
LQDA
Liquidia
2.6567 of 5 stars
$79.21
+0.4%
$68.88
-13.0%
+405.4%$7.02B$158.32M565.8350
BLCO
Bausch + Lomb
3.7085 of 5 stars
$17.10
-0.4%
$17.83
+4.3%
+17.1%$6.13B$5.10BN/A13,000

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners